WestEnd Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.9K | Hold |
65
| – | – | ﹤0.01% | 72 |
|
|
2025
Q4 | $13.5K | Sell |
65
-7
| -10% | -$1.38K | ﹤0.01% | 77 |
|
|
2025
Q3 | $13.3K | Sell |
72
-32
| -31% | -$5.48K | ﹤0.01% | 70 |
|
|
2025
Q2 | $15.9K | Buy |
104
+12
| +13% | +$1.84K | ﹤0.01% | 71 |
|
|
2025
Q1 | $15.3K | Buy |
92
+52
| +130% | +$8.14K | ﹤0.01% | 66 |
|
|
2024
Q4 | $5.78K | Buy |
40
+6
| +18% | +$930 | ﹤0.01% | 81 |
|
|
2024
Q3 | $5.51K | Sell |
34
-12
| -26% | -$1.91K | ﹤0.01% | 75 |
|
|
2024
Q2 | $6.72K | Sell |
46
-207,673
| -100% | -$30.9M | ﹤0.01% | 70 |
|
|
2024
Q1 | $32.9M | Buy |
207,719
+157
| +0.1% | +$25K | 0.85% | 31 |
|
|
2023
Q4 | $32.5M | Sell |
207,562
-6,753
| -3% | -$1.04M | 0.89% | 30 |
|
|
2023
Q3 | $33.4M | Buy |
214,315
+4,895
| +2% | +$808K | 1% | 25 |
|
|
2023
Q2 | $34.7M | Buy |
+209,420
| New | +$33.8M | 1.02% | 27 |
|
|
2023
Q1 | – | Sell |
-194,740
| Closed | -$31.4M | – | 29 |
|
|
2022
Q4 | $34.4M | Sell |
194,740
-11,086
| -5% | -$1.91M | 1.12% | 21 |
|
|
2022
Q3 | $33.6M | Sell |
205,826
-979
| -0.5% | -$166K | 1.13% | 18 |
|
|
2022
Q2 | $36.7M | Buy |
+206,805
| New | +$36.8M | 1.16% | 18 |
|
|
2022
Q1 | – | Sell |
-271,913
| Closed | -$46.3M | – | 20 |
|
|
2021
Q4 | $46.5M | Buy |
+271,913
| New | +$44.5M | 1.27% | 23 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 28 |
|
|
2021
Q2 | – | Sell |
-245,727
| Closed | -$40.7M | – | 29 |
|
|
2021
Q1 | $40.4M | Buy |
245,727
+13,132
| +6% | +$2.12M | 1.62% | 28 |
|
|
2020
Q4 | $36.6M | Sell |
232,595
-6,392
| -3% | -$943K | 1.85% | 27 |
|
|
2020
Q3 | $35.6M | Buy |
238,987
+5,643
| +2% | +$835K | 2.09% | 24 |
|
|
2020
Q2 | $32.8M | Buy |
233,344
+14,074
| +6% | +$2.05M | 2.2% | 21 |
|
|
2020
Q1 | $28.8M | Sell |
219,270
-28,564
| -12% | -$4.05M | 2.41% | 11 |
|
|
2019
Q4 | $36.2M | Buy |
247,834
+25,235
| +11% | +$3.42M | 2.73% | 8 |
|
|
2019
Q3 | $28.8M | Sell |
222,599
-17,673
| -7% | -$2.33M | 2.36% | 25 |
|
|
2019
Q2 | $33.5M | Buy |
+240,272
| New | +$33.3M | 2.91% | 20 |
|
|
2014
Q3 | – | Sell |
-965,706
| Closed | -$101M | – | 33 |
|
|
2014
Q2 | $101M | Sell |
965,706
-130,934
| -12% | -$13.2M | 4.95% | 12 |
|
|
2014
Q1 | $108M | Sell |
1,096,640
-330,417
| -23% | -$30.6M | 5.26% | 4 |
|
|
2013
Q4 | $131M | Sell |
1,427,057
-276,893
| -16% | -$25.5M | 4.72% | 16 |
|
|
2013
Q3 | $148M | Sell |
1,703,950
-89,461
| -5% | -$8.03M | 4.84% | 10 |
|
|
2013
Q2 | $154M | Buy |
+1,793,411
| New | +$152M | 5.06% | 5 |
|
Other funds holding JNJ
VCM
VPM
WestEnd Advisors's JNJ Position: Q1 2026 in Review
WestEnd Advisors held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 65 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #72.
WestEnd Advisors first reported a position in JNJ in Q2 2013 and has held it in 29 quarters since. The position peaked at $154M in Q2 2013. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- WestEnd Advisors held 65 shares of Johnson & Johnson worth $15.9K as of Q1 2026.
- WestEnd Advisors left its Johnson & Johnson share count unchanged in Q1 2026.
- Johnson & Johnson made up ﹤0.01% of WestEnd Advisors's portfolio in Q1 2026, its #72 holding.
- WestEnd Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 29 quarters since.
- WestEnd Advisors's Johnson & Johnson position peaked at $154M in Q2 2013.
- 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on WestEnd Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.